Table 1: Demographics and main clinical and pathological features of the analyzed series.

Parameters %

PSA
 <10 ng/mL18663.3
 10–20 ng/mL6622.4
 >20 ng/mL4214.3
Gleason-sp
 ≤611840.1
 713947.3
 8–10 3712.6
cT
 ≤cT2b27392.9
 ≥cT3a196.5
pT
 ≤pT216054.4
 ≥pT313345.2
pN*
 pN019064.6
 pN ≥ 1103.4
Perineural invasion
 Negative12642.7
 Positive14549.2

SP: specimen, cT: clinical stage, pT: pathological stage, PSA: prostatic-specific antigen, and pN: pathologic stage with respect to lymph node status.
Lymphadenectomy was limited to the obturator fossa in most of the cases at the inclusion period.